CIK 0001677077
- Emerging growth company
Alzamend Neuro, Inc.
Sign in to watch- Ticker
- ALZN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811822909
- Phone
- +1 844-722-6333
- Business address
- 480 PEACHTREE ROAD NE, SECOND FLOOR, SUITE 103, ATLANTA, GA, 30326
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,116
- in 1 filing
Net −$3,116. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-31 | Hyperscale Data, Inc. Director | Grant or award · Series D Convertible Preferred Stock | +7,500 | $1,000.00 | $7.5M | 7,500 |
| 2026-07-31 | Hyperscale Data, Inc. Director | Grant or award · Series D Convertible Preferred Stock | +7,500 | $1,000.00 | $7.5M | 7,500 |
Page 1 of 1 · 2 trades